Abstract:Photoresponsive ruthenium (Ru) complexes have been extensively studied in the photodynamic therapy (PDT) of cancer. The metal-to-ligand charge transfer (MLCT) absorption maximum of most Ru complexes is located in the short-wavelength visible region, which is well suited for superficial tumors but shows inefficient therapeutic effects for more deep-seated ones. Moreover, Ru complexes are primarily located in the mitochondria or nucleus, always resulting in high levels of dark toxicity and DNA mutation. Herein, we reported a new ruthenium complex (Ru-I) for red-light-triggered PDT. The activation wavelength of Ru-I is successfully extended to 660 nm. Importantly, the complex photosensitizer can be quickly taken up by cancer cells and selectively accumulated in the lysosome, an ideal localization for PDT purposes. Intratumoral injection of Ru-I into tumor-bearing mice achieved excellent therapeutic effects and thus holds great promise for applications in lysosome localization photodynamic therapy.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acsami.0c22551?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acsami.0c22551</a>.Experimental details including synthetic methods of Ru-I and characterization; ESI-HRMS spectrum of compound 3 (Figure S1); 1H NMR spectrum of compound 3 (Figure S2); ESI-HRMS spectrum of compound 4 (Figure S3); 1H NMR and 13C NMR spectra of compound 4 (Figure S4); purity of Ru-I measurement by HPLC (Figure S5); HOMO and LUMO orbitals for Ru-I (Figure S6); absorption and emission spectrum of Ru-I in different solvents (Figure S7); stability of Ru-I with different treatments (Figures S8 and S9); ROS generation analysis (Figures S10–S12); cell imaging experiments (Figures S13–S17); in vitro photocytotoxicity evaluation (Figures S18–S20); and animal experiments (Figures S21 and S22) (<a class="ext-link" href="/doi/suppl/10.1021/acsami.0c22551/suppl_file/am0c22551_si_001.pdf">PDF</a>)This article has not yet been cited by other publications.

A 700 Nm LED Light Activated Ru(II) Complex Destroys Tumor Cytoskeleton Via Photosensitization and Photocatalysis

Dinuclear Tridentate Ru(II) Complex with Strong Near-Infrared Light-Triggered Anticancer Activity

Novel Ru(II) complexes with multiple anticancer photoreactivity: ligand exchange, photoredox catalysis, reactive oxygen generation and endoperoxide formation

Red-Light-Responsive Ru Complex Photosensitizer for Lysosome Localization Photodynamic Therapy

Photoinduced synergistic cytotoxicity towards cancer cells <i>via</i> Ru(II) complexes

A ferrocenyl pyridine-based Ru(II) arene complex capable of generating center dot OH and O-1(2) along with photoinduced ligand dissociation

Biotin-conjugated Ru(II) complexes with AIE characteristics as mitochondria-targeted photosensitizers for enhancing photodynamic therapy by disrupting cellular redox balance

Converting an Almost Noncytotoxic Ru(II) Complex with Photolabile Ligands into a Highly Efficient PACT Agent

Photoactivation of Anticancer Ru Complexes in Deep Tissue: How Deep Can We Go?

A Near‐Infrared Light‐Activated Photocage Based on a Ruthenium Complex for Cancer Phototherapy

A Single-Molecular Ruthenium(ii) Complex-Based NIR-II Fluorophore for Enhanced Chemo-Photothermal Therapy

The Development of Ru(II)-Based Photoactivated Chemotherapy Agents.

Development of Ruthenium Nanophotocages with Red or Near‐Infrared Light‐Responsiveness

Donor–Acceptor–Donor Strategy Rouses the Photodynamic Therapy Anticancer Activity of a Bis-terpyridyl Ru(II) Complex

Ruthenium Complex-Modified Carbon Nanodots For Lysosome-Targeted One- And Two-Photon Imaging And Photodynamic Therapy

Noncovalent Ruthenium(II) Complexes-Single-Walled Carbon Nanotube Composites for Bimodal Photothermal and Photodynamic Therapy with Near-Infrared Irradiation.

Near Infrared Light-Mediated Photoactivation of Cytotoxic Re(i) Complexes by Using Lanthanide-Doped Upconversion Nanoparticles.

Bithiophene‐Functionalized Infrared Two‐Photon Absorption Metal Complexes as Single‐Molecule Platforms for Synergistic Photodynamic, Photothermal, and Chemotherapy

Near-infrared-activated Anticancer Platinum(iv) Complexes Directly Photooxidize Biomolecules in an Oxygen-Independent Manner

A Supramolecular Photosensitizer Derived from an Arene-Ru(II) Complex Self-Assembly for NIR Activated Photodynamic and Photothermal Therapy

A Tailored Multifunctional Anticancer Nanodelivery System for Ruthenium‐Based Photosensitizers: Tumor Microenvironment Adaption and Remodeling